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Background: Stroke remains one of the most common diseases with a serious impact on quality of life but few
effective treatments exist. Mild hypothermia (33°C) is a promising neuroprotective therapy in stroke management.
This study investigated whether a delayed short mild hypothermic treatment is still beneficial as neuroprotective
strategy in the endothelin-1 (Et-1) rat model for a transient focal cerebral ischemia. Two hours of mild hypothermia
(33°C) was induced 20, 60 or 120 minutes after Et-1 infusion. During the experiment the cerebral blood flow (CBF)
was measured via Laser Doppler Flowmetry in the striatum, which represents the core of the infarct. Functional
outcome and infarct volume were assessed 24 hours after the insult. In this sub-acute phase following stroke
induction, the effects of the hypothermic treatment on apoptosis, phagocytosis and astrogliosis were assessed as
well. Apoptosis was determined using caspase-3 immunohistochemistry, phagocytic cells were visualized by CD-68
expression and astrogliosis was studied by glial fibrillary acidic protein (GFAP) staining.
Results: Cooling could be postponed up to 1 hour after the onset of the insult without losing its positive effects
on neurological deficit and infarct volume. These results correlated with the caspase-3 staining. In contrast, the
increased CD-68 expression post-stroke was reduced in the core of the insult with all treatment protocols.
Hypothermia also reduced the increased levels of GFAP staining, even when it was delayed up to 2 hours after the
insult. The study confirmed that the induction of the hypothermia treatment in the Et-1 model does not affect
the CBF.
Conclusions: These data indicate that in the Et-1 rat model, a short mild hypothermic treatment delayed for 1 hour
is still neuroprotective and correlates with apoptosis. At the same time, hypothermia also establishes a lasting
inhibitory effect on the activation of astrogliosis.
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Stroke is an important cause of death worldwide and re-
combinant tissue plasminogen activator remains the only
approved treatment [1]. However, the limited time win-
dow for its administration restricts its usefulness. Given
the numerous pathways via which ischemia causes cell
death, the capacity to inhibit multiple mechanisms* Correspondence: Sophie.Sarre@vub.ac.be
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reproduction in any medium, provided the orsimultaneously may provide additive clinical benefits for
stroke patients [2,3]. Therapeutic hypothermia has given
positive effects in cardiac arrest and newborns with
hypoxic-ischemic encephalopathy [2,4,5]. A number of
small clinical trials have been performed in stroke patients
subjected to hypothermia, such as the “Cooling for Acute
Ischemic Brain Damage” study and the “Intravascular
Cooling in the Treatment of Stroke–Longer tPA window”
study [6,7]. Both studies confirmed that cooling patients is
feasible. However, no reduced mortality could be shown.
Several studies in animals have shown that although brieftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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protect against cerebral ischemia, longer durations are ne-
cessary when started in the post-ischemic period [8,9].
However, the risk of complications increases with treat-
ment duration, such as pneumonia hypovolemia, arrhyth-
mias, hyperglycemia, bradycardia, thrombocytopenia,
hypertension, hypotension, increased intracranial pressure,
electrolyte abnormalities like hypokalemia and metabolic
acidosis [7,10-13]. Evidently, hypothermic treatments
should be as short as possible. Indeed, with respect to the
well-known time is brain concept, it is crucial to induce a
beneficial effect as early as possible and to start a treat-
ment with as little side-effects as possible. Therefore, it is
essential that the ideal therapeutic time window of a short
hypothermic treatment should be determined in order to
avoid long cooling times and this without further impair-
ment of the neurological outcome. Many have proven that
2 hours of mild hypothermia is neuroprotective and can
reduce infarct volume after MCAO [3,9,14-26]. Experi-
mental research remains vital to establish the ideal length
of the therapeutic hypothermic treatment and this without
increasing hypothermia related complications [13,27-29].
As there is no ideal experimental stroke model, it is essen-
tial that such parameters are investigated in various ani-
mal models mimicking different types of stroke. In
contrast to other Middle Cerebral Artery Occlusion
(MCAO) models, the endothelin-1 (Et-1) model allows
the study of the effects of cooling during a slow reperfu-
sion phase [20,30-33]. Although longer cooling times
(minimum 12 hours) in rat models seem more protective
[34,35] than short ones (a few hours), investigation into ef-
ficient shorter cooling strategies remains relevant as long
hypothermic treatments may increase the risk of compli-
cations and/or have an influence on different organ sys-
tems [13,36]. We previously showed that a 2 hours mild
hypothermic treatment, started 20 minutes after the onset
of the insult can reduce infarct volume up to 1 week after
an Et-1 induced stroke. This beneficial effect was related
to effects on apoptosis, oxidative stress and the inflamma-
tory response [20,21,37].
Here, we investigated how long a short mild
hypothermic treatment can be postponed without redu-
cing its neuroprotective effect after a transient cerebral
ischemia induced by Et-1. The study investigated first
whether a hypothermia treatment exerts an effect on the
cerebral blood flow (CBF). Secondly, since apoptosis and
neuroinflammation are important pathways in cell death
in the subacute phase after ischemia, activated caspase-
3, phagocytosis (CD-68 expression) and astrogliosis (glial
fibrillary acidic protein (GFAP) staining) were investi-
gated. The effects were assessed after 24 hours since the
most pronounced effects of this hypothermic treatment
on apoptosis, phagocytosis and astrogliosis occur at that
time point.Methods
The experiments were performed according to the Na-
tional Guidelines on Animal Experimentation and
approved by the Ethical Committee for Animal Experi-
mentation of the Faculty of Medicine and Pharmacy of
the Vrije Universiteit Brussel.
Experimental and surgical protocols
Experiments were carried out in male Wistar rats weighing
270-300 g (Charles River Laboratories, IFFA-CREDO, Ger-
many). A day before the induction of the insult, 2 intracer-
ebral guide cannulas were stereotactically implanted under
anaesthesia (ketamine/diazepam 75:4 mg/kg i.p.) [21,37].
An Et-1 administration probe was positioned close to the
middle cerebral artery (MCA) (relative to bregma: AP
+0.9 mm; L +5.0 mm; V +2.8 mm) and a thermocouple
probe was positioned in the contralateral prefrontal cortex
(AP +3.2 mm; L −3.0 mm; V +2.3 mm) [38]. As post-
operative analgesia, the rats received 4 mg/kg ketoprofen
(i.p.). After surgery, the rats were allowed to recover over-
night. The next day the animals were anaesthetized with
4% sevoflurane (SevoraneW, Abbott, Kent, England) and
oxygen insufflated into a transparent chamber. During the
experiments, anaesthesia was maintained by 2% sevoflur-
ane with oxygen at 0.8 ml/min via a facemask. The guides
were replaced by a microdialysis probe without a mem-
brane (CMA, 3 mm probe with removed membrane,
Stockholm, Sweden) and a thermocouple probe (HYP-O-
SLE, Omega Corporation, Stamford, USA) to infuse Et-1
and measure the brain temperature respectively. Heart
rate, oxygen saturation and temperature were continuously
monitored during the experimental procedure. Transient
focal cerebral ischemia was induced by infusion of Et-1
(Sigma, St-Louis, MO, USA) dissolved in Ringer’s solution
(500pmol/6 μl) through the probe near the MCA at a flow
rate of 1 μl/min. In sham experiments, only Ringer’s solu-
tion was injected. By infusing Et-1 adjacent to the MCA, a
reproducible insult can be obtained in which the core is
represented by the striatum and the penumbra by the sur-
rounding cortex [21,37]. In normothermic rats, the brain
temperature was maintained at 37.0± 0.5°C throughout the
experiment using a heating pad and an infrared lamp. In
the hypothermic group, the temperature was reduced to
33.0 ± 0.5°C during 2 hours starting with a delay of 20, 60
or 120 minutes after the ischemic insult. Cooling the ani-
mal to the target temperature was achieved by spraying al-
cohol onto the animal and cooling it with a fan. With this
method the brain temperature can be decreased from 37.0
to 33.0°C within 10 minutes. A heating pad and an infrared
lamp were used to re-warm the animal from 33.0 to 37.0°C
in 30 minutes. Finally, all rats were kept at 37°C for an-
other 30 minutes before the anaesthesia was stopped.
Laser-doppler flowmetry experiments were preformed in
the striatum of some animals to investigated the influence
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four hours after the induction of the ischemic insult, the
effects on neurological outcome (neurological deficit
score), infarct volume, apoptosis (active caspase-3 staining)
and activation of microglia and astrocytes (CD-68 and
GFAP expression, respectively) were evaluated.
Experimental groups
In total, 44 rats were randomized into 6 experimental
groups (Figure 1). Sham rats (S group) were injected with
the vehicle of Et-1 and the brain temperature was kept
constant at 37.0 ± 0.5°C (n = 7) while in sham rats that
received the hypothermic treatment (S +H group, n = 4),
brain temperature was reduced to 33.0 ± 0.5°C. Nor-
mothermic rats (N group) were injected with Et-1. These
animals were not cooled and their brain temperature was
maintained at 37.0 ± 0.5°C (n = 12). Hypothermic rats
were infused with Et-1 and to determine how long the
hypothermic treatment protocol could be delayed, cool-
ing was started 20 (H20 group, n = 7), 60 (H60 group,
n = 7) or 120 minutes (H120 group, n = 7) after the infu-
sion of Et-1. As rats subjected to the 2 hours delayed
hypothermic protocol had to be sedated 100 minutes
longer than the H20 hypothermic protocol, we first
investigated if such prolonged anaesthesia did not affect
the parameters studied. Therefore, an extra group of nor-
mothermic rats was included in the study that received
prolonged sedation (100 minutes extra). The results
showed no differences in the determined parameters
when rats were subjected to the prolonged protocol.
Therefore, the results of all normothermic animals were
pooled and are always referred to as the N group.
Cerebral blood flow measurement
In 12 animals the CBF was measured during the entire
experimental procedure using laser Doppler flowmetry
(S, N and H group; n = 4 in each group). For these
experiments, an extra guide with canula was inserted
into the striatum during the surgical procedure (AP
+1.2, L +2.4, V +5.8, coordinates relative to bregma)
[38]. The next day when performing the experiment asFigure 1 Schematic overview of the different experimental groups indescribed above, this guide was replaced by a laser Dop-
pler probe (LaserFlo Blood perfusion monitor 403A,
fiber optic probe P336387). This allowed continuous
measurement of the CBF during the entire experimental
procedure. Basal levels of the CBF were equalled to
100% [39].
Behavioural testing
Sensor- and motoric abnormalities were evaluated before
and 24 hours after the administration of Et-1 with the
use of a neurological deficit score (NDS) as previously
described [37]. Six parameters were scored between 0 to
3 or 1 to 3. Spontaneous activity, symmetry in the move-
ment of the 4 limbs, forepaw outstretching, equality of
strength in the forepaws, body proprioception and re-
sponse to vibrissae touch was observed. The NDS was
calculated as the sum of these scores, 18 being the best
and 3 the worst possible score [37,40]. To ascertain un-
biased results, behavioural testing was performed by
observers, blinded to the treatment protocol.
Infarct volume determination
Exactly 24 hours after the infusion of Et-1, after the be-
havioural analysis, rats were deeply anaesthetized with
6% pentobarbital. The brains were fixated by a transcar-
dial perfusion with 5 minutes of saline and 5 minutes of
a freshly prepared 4% phosphate buffered paraformalde-
hyde solution and then stored in the same buffer. Cor-
onal sections of 50 μm were cut and stored in phosphate
buffered saline (PBS, 0.01 M) containing sodium azide
(0.1%) as a preservative. The infarct area was visualized
every 200 μm by a Nissl staining. At a magnification of
1.25, microscope pictures of the stained slices were
taken and transferred to the computer program Image J
(NIH, version 1.37) to calculate the infarct volume
stereologically. After scaling, the marked infarcted area
and hemisphere (in mm2) could be calculated and was
multiplied with the interspace. The influence of oedema
on the infarct volume was corrected by applying the fol-
lowing formula: (area of normal hemisphere/area of
infarcted hemisphere) x area of infarct [37,41]. Tocluded in this study.
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volume was performed by observers, blinded to the
treatment protocol.
Immunohistochemistry (IHC) for active caspase-3, CD-68
and GFAP
The degree of apoptosis was determined by IHC for ac-
tive caspase-3+-cells as previously described but with a
slightly modified protocol [20]. The 50 μm sections were
pre-incubated with 0.01% Triton X-100, 3% hydrogen
peroxide and blocking agent (Vectastain ABC kit, Vec-
torLaboratories, Burlingame, CA, USA). Next, the sec-
tions were incubated overnight at 4°C with a 1:250
dilution of the primary monoclonal rabbit anti-caspase-3
antibody (Cell Signaling, Westburg, The Netherlands).
The next day, the slices were incubated for 1 hour at
room temperature with biotinylated secondary antibody
(Vectastain ABC kit, VectorLaboratories, Burlingame,
CA, USA) and 30 minutes with ABC reagent with block-
ing solution (Vectastain ABC kit, VectorLaboratories,
Burlingame, CA, USA). Antibody binding was visualized
using the diaminobenzidine substrate chromogen kit
(DakoCytomation, Glostrup, Denmark). Between all
incubations, a washing step was included. After drying,
the sections were counterstained with haematoxylin/
lithium carbonate.
To determine the degree of neuroinflammation, the
activation status of microglia (CD-68 expression) and
astrocytes (GFAP expression) was determined as previ-
ously described [37]. After pre-incubation with 0.01%
Triton X-100, 3% hydrogen peroxide and pre-
immunized goat serum (1:5 dilution, Sigma, St-Louis,
MO, USA), brain slices were incubated overnight at 4°C,
with polyclonal mouse anti-CD-68 (1:1000 in PIG/PBS
1:5 dilution, AdB Serotec, Düsseldorf, Germany) or poly-
clonal rabbit anti-GFAP (1:10000 in PBS, DakoCytoma-
tion, Glostrup, Denmark). Next, the slices were
incubated for 4 hours at room temperature with a 1:100
dilution of either sheep anti-mouse or monkey anti-
rabbit secondary antibody (Amersham, GE Healthcare,
Buckinghamshire, UK). Antibody binding was visualized
using the diaminobenzidine substrate chromogen kit
(DakoCytomation, Glostrup, Denmark). Between all
incubations, a washing step was performed. After drying,
the sections were washed with water and dehydrated by
passing to graded alcohol and xylene.
For each rat, IHC protocols were performed on 3 inde-
pendent slices taken from 0.2 mm anterior to 0.26 mm
posterior to bregma to avoid interference of the implant-
ation of the Et-1 probe [38]. Alternate sections were used
for the determination of the infarct volume, apoptosis or
activation of glial cells. Positive caspase-3 stained cells
were counted using standard light microscopy. As previ-
ous research showed that hypothermia reduces the degreeof apoptosis only in the cortex after infusion of Et-1, but
not in the striatum, counting of active caspase-3+-cells
was limited to the cortex [20,21]. The total number of
caspase-3 positive cells was counted in the entire cortex of
the ischemic hemisphere. CD-68 positive cells were
counted in striatum and cortex [22,37]. For GFAP expres-
sion, the high density of cells did not allow counting.
Therefore, the relative staining intensity was calculated in
each rat: mean gray value ipsilateral striatum (or cortex) –
mean gray value contralateral striatum (or cortex), using
Image J (NIH, version 1.37). Besides, calculating the differ-
ence in intensity between the ipsi- and the contralateral
side is advantageous to correct for variations in circum-
stances when the IHC protocols were performed. To as-
certain unbiased results, counting was performed by
observers, blinded to the treatment protocol.
Correlation between the number of apoptotic cells, the
infarct volume and the NDS
The correlation between the number of apoptotic cells,
the infarct volume and the NDS was investigated. Each
point represents the mean of the S, N, H20, H60 and
H120 group. The calculated r2 values represent the coef-
ficient of determination (square of the Pearson correl-
ation coefficient) and are a measure for the extent to
which a variance in the two variables is shared.
Statistical analysis
All data are expressed as mean± SEM and a p-value <
0.05 was considered significant. Data analysis was per-
formed using the statistical program Graphpad InStat
(version 3.06 Windows XP, GraphPad Software, San
Diego, California, USA). To compare the results between
the different groups, a one-way ANOVA with Bonferroni
post-hoc test was used. For the changes of the CBF as a
function of time in each group, a repeated measures
ANOVA was used with Dunnett post-hoc test compared
to the CBF before the injection of Et-1.
Results
Mild hypothermia has no effect on the CBF
Sham animals showed no change in CBF during or
after administration of the vehicle. In normothermic
conditions, administration of 500 pmol Et-1 (at
t = 0 minutes) resulted in an immediate significant re-
duction in CBF for 20 minutes to approximately 20%
of the baseline values. Forty minutes after the insult,
a slight hyperperfusion phase could be distinguished
during which the CBF increased to about 110% of
baseline values. Gradually, however, the CBF
decreased back to approximately 75% of basal values.
The hypothermic treatment, started 20 minutes after
the Et-1 administration, had no effect on the changes
in blood flow observed in normothermic conditions.
Figure 3 Effect of hypothermic treatments on the Et-1 induced
changes in neurological deficit score (NDS). The S and S +H
group showed no significant decrease in NDS (n = 7 and 4
respectively). Delaying hypothermia (n = 7 in each H group) up to
60 minutes after the induction of the insult, still improved
neurological deficit. *Significantly different (p < 0.05) from N group
(n = 12). }Significantly different (p < 0.05) from each other.
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affect the CBF (Figure 2).
Delaying hypothermia up to 1 hour after the
administration of Et-1 is still neuroprotective and
improves functional and neurological outcome
The minor surgery required to implant the probe by
which Et-1 was administered, had no effect on the
NDS (data not shown). Comparison of the NDS be-
fore infusion (control) of vehicle in the sham rats and
24 hours afterwards showed no significant difference.
The NDS of the S +H group was not different from
the control group. Et-1 administration in normother-
mic conditions significantly reduced the NDS com-
pared to the sham rats. The NDS in the H20, 60 or
120 group was also lower than in the S group. The
hypothermic treatment initiated either 20 or 60 min-
utes after the ischemic insult significantly improved
the neurological deficit compared to the normother-
mic group, whereas the treatment initiated after
120 minutes was ineffective (Figure 3).
Sham operated animals (S and the S +H group)
showed no infarct, while in the normothermic rats a
large area of damaged tissue stretching from the stri-
atum (the core of the insult) into the surrounding
cortex (the penumbra) was present. Hypothermia,
initiated 20 minutes after the insult reduced the in-
farct volume by almost half. Salvation of tissue byFigure 2 Effect of the hypothermic treatment on the CBF after injecti
CBF in sham, normothermic or hypothermic animals (n = 4 in each group),
injection of Et-1 or vehicle. The hypothermia treatment in the Et-1 model d
point 0 min. }Significantly different (p < 0.05) compared to the sham grouphypothermia predominantly took place in the pen-
umbral region, in accordance with previous findings
from our laboratory [21,37]. Hypothermia, initiated
60 minutes after the ischemic insult, also signifi-
cantly reduced the infarct volume. However, when
the hypothermic treatment was delayed up to 2 hours
after the insult, the infarct volume did not show anyon of Et-1. The graph shows the percentage increase or decrease in
compared to basal values (equal to 100%) which were assessed before
oes not affect the CBF. *Significantly different (p < 0.05) from the time
.
Figure 4 Effect of hypothermic treatments on the Et-1 induced infarct volume. There was no infarct volume in the S and the S +H group
(n = 7 and 4 respectively, data not shown). (A) Delaying hypothermia up to 60 minutes after the administration of Et-1 still induced enough
neuroprotection to reduce the infarct volume significantly. The amount of animals in each hypothermic group was 7. *Significantly different
compared to the infarct volume of the N group (n = 12). }Significantly different from each other (p < 0.05). (B) shows the infarct volume for the
different treatment protocols.
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rats anymore (Figure 4).
Hypothermia reduces the amount of active caspase-3+-cells
by half, even if only initiated 1 hour after the
administration of Et-1
No positive staining was observed in sham rats (S and
S +H group) and in the hemisphere contralateral to the
site of Et-1 infusion. Administration of Et-1, on the
other hand, resulted in a massive increase in apoptotic
cell death (Figure 5). The hypothermic treatment
initiated 20 or 60 minutes after the insult resulted in a
50 or 45% reduction in apoptotic cells respectively.
However, starting hypothermia as late as 2 hours after
the Et-1 administration did not reduce the amount ofapoptotic cells significantly, compared to normothermic
rats.
The number of apoptotic cells correlates well with the
infarct volume and the NDS
The number of apoptotic cells correlated well with in-
farct volume (r2 = 0.96) and even better with the NDS
(r2 = 0.99) (Figure 6). The NDS also correlated well with
the infarct volume (r2 = 0.96) (data not shown).
Delaying hypothermia up to 2 hours after stroke onset,
still reduces CD-68 expression but not GFAP expression
Cerebral ischemia induces neuroinflammation which is
initiated by activation of microglia and their transformation
into resident macrophages and subsequent infiltration of
Figure 5 Effect of hypothermic treatments on the Et-1 induced
changes in active caspase-3+-cells in the cortex. (A) shows the
active caspase-3+-cells of a normothermic rat, while (B) in a
hypothermic animal. Graph (C) shows the overall expression of active
caspase-3+-cells of the N group (n= 12) and the H20, H60 and H120
group, (n= 7 in each group), in the ischemic hemisphere. There was
no staining in the S and the S+H group (n= 7 and 4 respectively, data
not shown), and in the contralateral hemisphere of the other groups.
Delaying hypothermia up to 60 minutes after the administration of Et-
1, reduced the Et-1 induced apoptosis significantly. There was no
binding of the second antibody in the absence of the primary
antibody (data not shown). *Significantly different compared to the N
group. }Significantly different (p< 0.05) from each other.
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borne and resident macrophages/activated microglia can
be visualized by anti-CD-68 staining. No positive staining
was observed in the hemisphere contralateral to the site ofEt-1 infusion. Sham operated rats showed a low number of
CD-68+-cells in the striatum, in contrast to the cortex,
where a significant amount of CD-68+-cells was observed.
Cooling down sham rats reduced the expression of CD-68
in the cortex. Administration of Et-1 resulted in an
increased CD-68 expression in striatum and cortex, in ac-
cordance with previous findings [37]. The hypothermic
treatment, even if delayed up to 2 hours after the infusion
of Et-1 significantly reduced the amount of phagocytic cells
in the striatum. However, in the cortex, although a strong
reduction in CD-68+-cells was visible after all treatment
protocols, this effect was only statistically significant for
the H20 group (Figure 7).
Activated astrocytes were visualized by IHC for GFAP.
Low expression of GFAP was present in the striatum
and the cortex of the sham rats (S and S +H group).
Consistent with our previous findings, a massive in-
crease in GFAP expression occurred in the striatum and
cortex of the normothermic animals. Hypothermic treat-
ment after Et-1 significantly reduced the GFAP expres-
sion even when hypothermia was delayed for 2 hours
after the insult. The strongest reduction in GFAP ex-
pression was observed in the striatum of the H20 group.
The levels of the H60 group were higher than the H20
group, but stayed significantly lower than the untreated
N group. The same was seen in the H120 group but the
levels decreased again slightly compared to the H60
group, although not significantly different from each
other. Reduction in GFAP expression was also observed
in the cortex but was less pronounced than in the stri-
atum (Figure 8).
Discussion
It is generally accepted that reducing the body temperature
to 33-34°C is neuroprotective against cerebral ischemic
insults without causing many side effects [9,28,29]. Here,
we show that, in the Et-1 model, a short mild hypothermic
treatment can be delayed up to 1 hour after stroke onset
without losing its beneficial effect. Although the reduction
in neurological and functional deficit and apoptosis was no
longer observed after delaying hypothermia for 2 hours,
this study clearly shows a lasting inhibitory effect on activa-
tion of glia. Laser-doppler flowmetry experiments in the
striatum showed no influence of cooling on the MCA
occlusion caused by Et-1. Finally, we show a clear correl-
ation between neurological and functional outcome with
apoptosis but not with inflammation.
The STAIR criteria suggest to reproduce data in as
many experimental stroke models as possible, especially
in models mimicking hospital settings. In the Et-1
model, as reperfusion is only established slowly, it
resembles clinical reality closely and thus data could be
extrapolated to the clinic [42]. Besides, due to the short
half-life of Et-1 (1.4 to 3.6 minutes) [43], infusion of this
Figure 6 Correlation between the number of apoptotic cells and the infarct volume, and the NDS. Each point represents the mean of the
S, N, H20, H60 and H120 group. The number of apoptotic cells correlates well with infarct volume (r2 = 0.96) and with the NDS (r2 = 0.99).
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MCA for 20–30 minutes, before a gradual reperfusion
[39]. Afterwards the blood flow is restored. As such, a
reproducible infarct with a clear distinction between the
core (striatum) and the penumbra (cortex) of the insult
is established and it becomes possible to distinguish cer-
tain effects solely to the core or penumbral area [21,37].
Our study showed that cooling had no influence on the
MCAO caused by Et-1. This result indicates that the
effects of hypothermia are not mediated by modulation
of the CBF.
Since cells in the penumbra undergoing apoptosis are
major targets for intervention [44], we assessed the num-
ber of cells containing active caspase-3. Previously, we
demonstrated that apoptosis in the penumbra occurs in
the subacute phase and peaks 24 hours after the insult
[20]. Chaitanya et al. [45] showed that 3 hours MCAO
induces apoptosis, reaching maximal levels at 24 and
72 hours after the insult [45]. Another study investigated
the effect of 20 minutes and 2 hours MCAO on apoptosis.
They observed that caspase-3 activity peaks at 24 and
72 hours after reperfusion in the 20 minutes MCAO
group, whereas, it only peaks at 24 hours after 2 hours
MCAO [46]. These results are consistent with our data.
Previous research in our laboratory also investigated nu-
clear fragmentation in neuronal cells and showed 24 hours
after the insult that mild hypothermia significantly
affected apoptotic neuronal cell death in the penumbral
region, consistent with the effects observed here on acti-
vated caspase-3 expression [21]. Phanithi et al. [47]
showed that intra-ischemic mild hypothermia inhibits the
caspase-3 expression in the penumbra, at 24 hours, after
1 hour of focal ischemia [47]. Maier et al. [9] confirmed
that 1 and 2 hours of intra-ischemic mild hypothermia
was effective to reduce apoptosis at 72 hours after theinsult [9]. Similar results on infarct volume have been
reported. For instance, Maier et al. [19] showed, 3 days
after the insult, that 2 hours of hypothermia reduced the
infarct volume, even when delayed up to 90 minutes after
2 hours MCAO [19]. In the same MCAO model, 4 hours
of post-ischemic hypothermia (started 4 hours after ische-
mia onset), could no longer protect the rat brain [48,49].
However, a study by Ohta [50] showed that the
hypothermic treatment could be delayed up to 4 hours
after 2 hours MCAO if cooling was prolonged for 48 hours
[50]. However, serious side effects are then to be expected,
but were not investigated.
In our study, the number of apoptotic cells correlates
well with infarct volume (r2 = 0.96) and with neurological
deficit (r2 = 0.99). This observation is in accordance with
the general idea that cell death in the penumbra, which
is the predominant area that is salvaged by hypothermia,
occurs through apoptosis [19-21,44]. It is also coherent
with our hypothesis that the beneficial effects of short
hypothermic treatment on infarct volume and neuro-
logical deficit are predominantly mediated by inhibition
of apoptosis in the penumbra, at least as established at
24 hours after the insult.
After infusion of Et-1, CD-68 expression increased in
the striatum and the cortex of the insult after 24 hours.
These results are consistent with previous findings in the
Et-1 model [37] and other MCAO models [51-53]. The
hypothermic treatment significantly attenuated this in-
crease by approximately 50%, when initiated 20 minutes
after the infusion of Et-1. Similar results were obtained in
studies investigating the effect of 2 hours of intra-
ischemic mild hypothermic treatment after 2 hours
MCAO. They showed a reduction of the infarct volume
and CD-68 expression at 1, 3 and 7 days after the insult
[15,16,22]. Similar results were also observed after
Figure 7 Effect of hypothermic treatment on the Et-1 induced increase in CD-68 expression. (A) shows the expression of CD-68 in a rat of
the N group and (B) in a rat of the H20, H60 and H120 group, respectively. The graphs show the overall expression in the striatum (C) and the
cortex (D) for the different treatment protocols. The number of rats in the S and S +H group is 7 and 4 respectively; in the N group 12 and in
every H group 7. Data are expressed as the number of cells/mm2. There was no binding of the second antibody in the absence of the primary
antibody (data not shown). *Significantly different compared to the N group. For a more detailed image we refer to a previously published article
by Ceulemans et al. [37].
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delaying hypothermia for 1 or 2 hours could still reduce
the amount of phagocytic cells in the core of the insult.
Surprisingly, this observation did not correlate with
decreased neurological or functional deficit. This could
mean that a reduction in phagocytosis is not instrumental
to the neuroprotective effects of hypothermia. However, it
is conceivable that inhibition of microglial activation and
reduced infiltration of monocytes within the first 24 hours
attenuates the induction of cell death between 24 and
72 hours after the insult.
GFAP is considered the best marker to investigate re-
active gliosis [55]. Stroke induces a massive increase in
GFAP expression after a day, in several stroke models
ranging from 30 minutes MCAO to the photothrombo-
sis model [56,57]. Our study confirms these results in
the Et-1 model, in the core as well as in the penumbra.Our major finding is that short hypothermic treatment
reduced the expression of GFAP in the striatum and cor-
tex. More specifically, Zoli et al. [57] described peak
levels in astrogliosis 24 hours after the insult, especially
in the penumbral area [57]. Our results are consistent
with these findings and might explain why the effect of
hypothermia on GFAP expression was less pronounced
compared to that in the core of the insult. Although the
strongest effects were found when hypothermia was
initiated after 20 minutes, delaying hypothermia up to
2 hours after the administration of Et-1 still reduces
GFAP expression. Further research is necessary to clarify
whether delaying short hypothermic treatment for
2 hours (or more) provides neuroprotection at later time
points after the insult. However, it is also possible that
increased GFAP expression after cerebral ischemia is not
entirely detrimental. Indeed, GFAP null mice showed
Figure 8 Effect of hypothermic treatment on the Et-1 induced increase in GFAP expression. Activation of astrocytes as determined by the
expression of GFAP (A) in a N rat and (B) in a H20, H60 and H120 rat, 24 hours after the administration of Et-1. The graphs show the overall
expression in striatum (C) and cortex (D) of the different treatment protocols. The number of rats in the S and S +H group is 7 and 4 respectively;
in the N pool 12 and in every H group 7. *Significantly different compared to the N group. }Significantly different (p < 0.05) from each other. For a
more detailed image we refer to a previously published article by Ceulemans et al. [37].
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[58,59].
This study confirms that short hypothermic treatment
can be protective when it is applied within a relatively
short therapeutic window up to 1 h. It is known that,
when the treatment is delayed, long cooling periods
seem more protective [34,35]. In a balance of risk and
benefit, a short duration of hypothermia may be the ini-
tial choice. The hypothermia treatment protocol should
be tailored to each patient's situation, depending on the
time after the insult and whether the patient is in the
intra-ischemic or in the post-ischemic period. For in-
stance, shorter cooling periods can be induced when
patients arrive very quickly in the hospital after the onset
of the insult, while longer cooling periods can be applied
to patients that arrive later to the hospital. Also co-
morbidities should be taken into account when conduct-
ing experimental or clinical studies [13]. Based on thisassumption and the results of the available data, a larger
randomized, controlled clinical trial of hypothermia in
acute ischemic stroke is warranted.Conclusion
Administration of Et-1 resulted in an ischemic stroke
associated with neurological deficit and a large infarct
volume, 24 hours after the insult. Furthermore, apop-
tosis and gliosis were stimulated. Two hours of a short
mild hypothermic treatment, initiated after 20 or 60 min-
utes improved neurological deficit and infarct volume,
and coincided with a reduction in apoptotic cells. Glial
activation, on the contrary, remained inhibited even
when hypothermia was only induced after 2 hours.
These data indicate that in the Et-1 rat model, a short
mild hypothermic treatment delayed for 1 hour is still
neuroprotective and correlates with apoptosis. At the
Zgavc et al. BMC Neuroscience 2012, 13:105 Page 11 of 12
http://www.biomedcentral.com/1471-2202/13/105same time, hypothermia also establishes a lasting inhibi-
tory effect on the activation of astrogliosis.
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